Lipum
lipum.se
Actively hiring
Immunology & Inflammation Therapeutics
Biologics & Biosimilars
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$8.1M
1 round on record
Latest round
$8.1M
Venture round · Apr 2021 · 5 yr ago
Team
11-50
employees, estimated range
Backers
1
Flerie
The money's age
Long since its last round
65 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 20, 2021
Raised a round Venture round $8.1M · Mynewsdesk
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Apr 2021 | $8.1M | — | Mynewsdesk |
Founders and leadersfrom filings, registers and the company's site
Scientific AdvisoryDirectorscompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
Flerie Similar startupsby what they do, their industry and backers
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory…
We believe that clinical remission should be the standard—not the exception—for treating chronic inflammatory diseases like COPD, asthma…
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
CAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor…
ApogeeTherapeutics. Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe…
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a…
News
Lipum AB: Lipum AB - Year-end report 2025
Lipum AB (publ) has published the Q4 interim and year-end report for 2025. Below is a summary, a complete report (only in Swedish) is available on the company's website.Financial summary January - December
Read more
Report
Lipum AB (publ) publie ses résultats financiers pour le troisième trimestre et les neuf premiers mois clos le 30 septembre 2025
Read more
Report
Búsqueda de símbolos en Yahoo Finanzas
Busca símbolos en la pizarra para acciones, fondos comunes de inversión, ETF, índices y contratos a futuro en Yahoo Finanzas.
Read more
Report
BioStock: Chairman on Lipum's progress, vision, and challenges
Ingemar Kihlström has been a member of Lipum's board since 2021 and currently serves as its
Read more
Report
Annons: Lipum utvecklar ett unikt läkemedel mot ledgångsreumatism
Det svenska företaget Lipum utvecklar ett unikt läkemedel för behandling av reumatism, vilket är ett samlingsnamn för ett stort antal olika kroniska…
Read more
Report
Lipum's toxicology- and safety studies on the candidate drug SOL-116 progress according to plan
Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum's
Read more
Report
Report
Lipum raises SEK 85 million and become listed on Nasdaq First North
Umeå-based biopharmaceutical company Lipum has been working towards a stock exchange listing since 2018 - and now the moment has finally arrived. On...
Read more
Report
Show more news
People
Scientific Advisory
Directors
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Financials
Total raised
$8.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | $8.1M | Details |